Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans

Fasiha Kanwal, Jennifer R. Kramer, Zhigang Duan, Xiaoying Yu, Donna White, Hashem B. El-Serag

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. However, few data are available on recent trends in the incidence and prevalence of NAFLD in the U.S. Methods: We analyzed the national Veterans Administration databases from 2003 to 2011 and calculated the age-adjusted prevalence and incidence of NAFLD for the overall sample of patients and by demographic subgroups. We used a previously validated algorithm to define NAFLD, which was based on persistent increases in levels of liver enzymes in the absence of positive results from tests for hepatitis C or hepatitis B or evidence of excessive alcohol use. Results: Of the 9,784,541 patients with at least 1 visit to the Veterans Administration between 2003 and 2011, 1,330,600 patients (13.6%) had NAFLD. The annual incidence rates of NAFLD remained stable (from 2.2% to 3.2%) during the study duration. The prevalence of NAFLD increased from 6.3% in 2003 (95% confidence interval, 6.26%-6.3%) to 17.6% in 2011 (95% confidence interval, 17.58%-17.65%), a 2.8-fold increase. The incidence and prevalence increased at significantly greater rates in patients younger than 45 years vs older patients. Conclusions: In a U.S. population, the annual incidence of NAFLD ranges from 2% to 3%. The prevalence of NAFLD more than doubled from 2003 through 2011; it is likely to continue to increase because of a steady overall incidence coupled with a rising incidence in younger individuals.

Original languageEnglish (US)
Pages (from-to)301-308
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume14
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Veterans
Incidence
United States Department of Veterans Affairs
Confidence Intervals
Non-alcoholic Fatty Liver Disease
Hepatitis C
Hepatitis B
Liver Diseases
Chronic Disease
Alcohols
Demography
Databases
Liver
Enzymes

Keywords

  • Epidemiology
  • Incidence
  • Metabolic Syndrome
  • Nonalcoholic Fatty Liver Disease
  • Prevalence

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. / Kanwal, Fasiha; Kramer, Jennifer R.; Duan, Zhigang; Yu, Xiaoying; White, Donna; El-Serag, Hashem B.

In: Clinical Gastroenterology and Hepatology, Vol. 14, No. 2, 01.02.2016, p. 301-308.

Research output: Contribution to journalArticle

Kanwal, Fasiha ; Kramer, Jennifer R. ; Duan, Zhigang ; Yu, Xiaoying ; White, Donna ; El-Serag, Hashem B. / Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. In: Clinical Gastroenterology and Hepatology. 2016 ; Vol. 14, No. 2. pp. 301-308.
@article{bb9344d9b7dc4f65b79108238980991d,
title = "Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans",
abstract = "Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. However, few data are available on recent trends in the incidence and prevalence of NAFLD in the U.S. Methods: We analyzed the national Veterans Administration databases from 2003 to 2011 and calculated the age-adjusted prevalence and incidence of NAFLD for the overall sample of patients and by demographic subgroups. We used a previously validated algorithm to define NAFLD, which was based on persistent increases in levels of liver enzymes in the absence of positive results from tests for hepatitis C or hepatitis B or evidence of excessive alcohol use. Results: Of the 9,784,541 patients with at least 1 visit to the Veterans Administration between 2003 and 2011, 1,330,600 patients (13.6{\%}) had NAFLD. The annual incidence rates of NAFLD remained stable (from 2.2{\%} to 3.2{\%}) during the study duration. The prevalence of NAFLD increased from 6.3{\%} in 2003 (95{\%} confidence interval, 6.26{\%}-6.3{\%}) to 17.6{\%} in 2011 (95{\%} confidence interval, 17.58{\%}-17.65{\%}), a 2.8-fold increase. The incidence and prevalence increased at significantly greater rates in patients younger than 45 years vs older patients. Conclusions: In a U.S. population, the annual incidence of NAFLD ranges from 2{\%} to 3{\%}. The prevalence of NAFLD more than doubled from 2003 through 2011; it is likely to continue to increase because of a steady overall incidence coupled with a rising incidence in younger individuals.",
keywords = "Epidemiology, Incidence, Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, Prevalence",
author = "Fasiha Kanwal and Kramer, {Jennifer R.} and Zhigang Duan and Xiaoying Yu and Donna White and El-Serag, {Hashem B.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.cgh.2015.08.010",
language = "English (US)",
volume = "14",
pages = "301--308",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans

AU - Kanwal, Fasiha

AU - Kramer, Jennifer R.

AU - Duan, Zhigang

AU - Yu, Xiaoying

AU - White, Donna

AU - El-Serag, Hashem B.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. However, few data are available on recent trends in the incidence and prevalence of NAFLD in the U.S. Methods: We analyzed the national Veterans Administration databases from 2003 to 2011 and calculated the age-adjusted prevalence and incidence of NAFLD for the overall sample of patients and by demographic subgroups. We used a previously validated algorithm to define NAFLD, which was based on persistent increases in levels of liver enzymes in the absence of positive results from tests for hepatitis C or hepatitis B or evidence of excessive alcohol use. Results: Of the 9,784,541 patients with at least 1 visit to the Veterans Administration between 2003 and 2011, 1,330,600 patients (13.6%) had NAFLD. The annual incidence rates of NAFLD remained stable (from 2.2% to 3.2%) during the study duration. The prevalence of NAFLD increased from 6.3% in 2003 (95% confidence interval, 6.26%-6.3%) to 17.6% in 2011 (95% confidence interval, 17.58%-17.65%), a 2.8-fold increase. The incidence and prevalence increased at significantly greater rates in patients younger than 45 years vs older patients. Conclusions: In a U.S. population, the annual incidence of NAFLD ranges from 2% to 3%. The prevalence of NAFLD more than doubled from 2003 through 2011; it is likely to continue to increase because of a steady overall incidence coupled with a rising incidence in younger individuals.

AB - Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States. However, few data are available on recent trends in the incidence and prevalence of NAFLD in the U.S. Methods: We analyzed the national Veterans Administration databases from 2003 to 2011 and calculated the age-adjusted prevalence and incidence of NAFLD for the overall sample of patients and by demographic subgroups. We used a previously validated algorithm to define NAFLD, which was based on persistent increases in levels of liver enzymes in the absence of positive results from tests for hepatitis C or hepatitis B or evidence of excessive alcohol use. Results: Of the 9,784,541 patients with at least 1 visit to the Veterans Administration between 2003 and 2011, 1,330,600 patients (13.6%) had NAFLD. The annual incidence rates of NAFLD remained stable (from 2.2% to 3.2%) during the study duration. The prevalence of NAFLD increased from 6.3% in 2003 (95% confidence interval, 6.26%-6.3%) to 17.6% in 2011 (95% confidence interval, 17.58%-17.65%), a 2.8-fold increase. The incidence and prevalence increased at significantly greater rates in patients younger than 45 years vs older patients. Conclusions: In a U.S. population, the annual incidence of NAFLD ranges from 2% to 3%. The prevalence of NAFLD more than doubled from 2003 through 2011; it is likely to continue to increase because of a steady overall incidence coupled with a rising incidence in younger individuals.

KW - Epidemiology

KW - Incidence

KW - Metabolic Syndrome

KW - Nonalcoholic Fatty Liver Disease

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84958919495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958919495&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2015.08.010

DO - 10.1016/j.cgh.2015.08.010

M3 - Article

VL - 14

SP - 301

EP - 308

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 2

ER -